Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2006, p. 699-708, Vol. 26, No. 2
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.2.699-708.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Martin Holcik,1,
Charles A. Lefebvre,3
Eric LaCasse,3
David J. Picketts,4
Kathryn E. Wright,2 and
Robert G. Korneluk1,2,3*
Apoptosis Research Center, Children's Hospital of Eastern Ontario, Ottawa, K1H 8L1 Ontario, Canada,1 Ægera Oncology Inc., Ottawa, K1H 8L1 Ontario, Canada,3 Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, K1H 8M5 Ontario, Canada,2 Ottawa Health Research Institute, Ottawa, K1H 8L6 Ontario, Canada4
Received 20 May 2005/ Returned for modification 24 June 2005/ Accepted 23 October 2005
The cellular inhibitor of apoptosis 2 (cIAP2/HIAP1) is a potent inhibitor of apoptotic death. In contrast to the other members of the IAP family, cIAP2 is transcriptionally inducible by nuclear factor-
B in response to multiple triggers. We demonstrate here that cIAP2/ mice exhibit profound resistance to lipopolysaccharide (LPS)-induced sepsis, specifically because of an attenuated inflammatory response. We show that LPS potently upregulates cIAP2 in macrophages and that cIAP2/ macrophages are highly susceptible to apoptosis in a LPS-induced proinflammatory environment. Hence, cIAP2 is critical in the maintenance of a normal innate immune inflammatory response.
D.C. and M.H. contributed equally to this study.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»